TScan Announces Collaboration with Novartis on the Discovery and Development of Novel T Cell Receptor Therapies for the Treatment of Solid Tumors April 15, 2020
TScan Founders Lea Hachigian and Tomasz Kula Named in Forbes 2020 “30 Under 30” List December 10, 2019
TScan Therapeutics Announces Pioneering Publication in Scientific Journal Cell Describing New Methods to Identify Targets for T Cell Receptor Immunotherapy August 12, 2019
